2016 American Transplant Congress

Sunday, June 12, 2016

3:18pm-3:30pm

AT1R Antibodies at 1-Year Negatively Impact 5-Year Native Renal Function in Liver Transplant Recipients.

J. O'Leary,¹ A. Philippe,² H. Heidecke,² R. Freeman,¹ L. Jennings,¹ R. Catar,² G. Klintmalm,¹ D. Dragun.²

Concurrent Session: The Kidney in Liver Transplantation  •  Room 302

3:18pm-3:30pm

Complexity of Hylinosis in Renal Transplant Biopsies: Donor Age, Glomerular Disease, and Time.

G. Einecke,¹ J. Reeve,² P. Halloran.^2,3

Concurrent Session: Novel Markers of Long Term Kidney Transplant Outcomes  •  Ballroom A

3:18pm-3:30pm

Donor-Recipient Absolute Weight Mismatch and the Risk of Graft Loss in Renal Transplantation.

A. Miller,¹ B. Kiberd,¹ I. Alwayn,² K. Tennankore.¹

Concurrent Session: Kidney Transplantation: Outcomes, Matching and Marginal Donors  •  Ballroom B

3:18pm-3:30pm

Impact of Low Dose Tacrolimus with Everolimus Regimen on Renal Pathology and T-Regulatory Cells in Kidney Transplant.

A. Shetty,¹ T. Opas,¹ J. Mathew,¹ V. Mas,² J. Leventhal,¹ N. Sustento-Reodica,¹ L. Gallon.¹

Concurrent Session: Kidney Transplant: CNI Minimization  •  Room 311

3:18pm-3:30pm

Mycophenolic Acid Product Discontinuation Prior to Conception: Analysis of Pregnancies in Kidney Transplant Recipients.

S. Constantinescu,^1,2 L. Coscia,² D. Armenti,² M. Moritz.^2,3

Concurrent Session: Policy and Practice: Implications for Long Term Outcomes  •  Room 312

3:18pm-3:30pm

Risk Prediction of End-Stage Renal Disease in Living Kidney Donors.

A. Massie, E. Chow, D. Segev.

Concurrent Session: Living Kidney Donation: Risk Factors for Adverse Long term Outcome  •  Veterans Auditorium

3:18pm-3:30pm

Sociodemographic and Comorbidity Differences Between Dialysis, Waitlisted and Transplant Patients in the UK: Findings from the ATTOM Study.

D. Wu,¹ M. Robb,² C. Watson,³ R. Ravanan,⁴ J. Forsythe,¹ A. Bradley,³ G. Oniscu.¹

Concurrent Session: Cardiovascular Complications in Kidney Transplantation  •  Room 304

3:18pm-3:30pm

The Effect of Donor Age on Acute Rejection Age – The Clinical Impact of Donor Immuno-Senescence in the Modern Immunosuppressive Era.

U. Khalid, P. Donato, L. Szabo, R. Chavez, E. Ablorsu, A. Asderakis.

Concurrent Session: Kidney Acute Cellular Rejection: Clinical Outcomes and Pathological Characteristics  •  Ballroom C

3:18pm-3:30pm

The Impact of Complement Binding Donor Specific Antibodies in the First Year After Heart Transplantation.

J. Patel, M. Kittleson, D. Chang, T. Aintablian, A. Velleca, D. Ramzy, L. Czer, J. Kobashigawa.

Concurrent Session: Challenges in Hearts and VADs - Striking Back  •  Room 309

3:18pm-3:30pm

The Use of Sofosbuvir (SOF)-Containing Direct Antiviral Agents (DAA)-Based Regimens Requires Increase in Tacrolimus (Tac) Doses in Kidney Transplant (KT) Recipients with Hepatitis C Virus (HCV) Infection.

N. Polanco Fernandez,¹ A. García Santiago,¹ M. Fernández Ruiz,² R. Muñoz,³ C. Alvarez Vazquez,⁴ A. Hernandez,¹ V. Mercado,¹ E. González Monte,¹ I. Fernández,³ J. Aguado,² M. Praga,¹ A. Andres.¹

Concurrent Session: SOT: HIV, HBV, & HCV  •  Room 313